(Q80387916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

Tomokazu Kawaoka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

11

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

10

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

9

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

6

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

Yusuke Kawamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

25 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

395-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

31 December 2019

cites work

1 reference

12 December 2020

Alterations in the human immune response to the hepatitis B vaccine among the elderly

1 reference

12 December 2020

Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan.

1 reference

12 December 2020

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

12 December 2020

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.

1 reference

12 December 2020

Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study.

1 reference

12 December 2020

Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop

1 reference

12 December 2020

Viral hepatitis in older adults

1 reference

12 December 2020

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

12 December 2020

Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus.

1 reference

12 December 2020

Global programme for control of hepatitis B infection

1 reference

12 December 2020

Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis

1 reference

12 December 2020

Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study

1 reference

12 December 2020

Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

1 reference

12 December 2020

Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy

1 reference

12 December 2020

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

1 reference

12 December 2020

Virological and biochemical relapse according to YMDD motif mutant type during long‐term lamivudine monotherapy

1 reference

12 December 2020

Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort study

1 reference

12 December 2020

Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C.

1 reference

12 December 2020

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

12 December 2020

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.

1 reference

12 December 2020

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

12 December 2020

Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B.

1 reference

12 December 2020

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

12 December 2020

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.

1 reference

12 December 2020

10.1007/S00535-007-2015-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530365%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference